Clinical Trial Update: A Study (Phase 1b/2) of GS3-007a Oral Treatment in Children With Growth Hormone Deficiency (PGHD) [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1b/2 trial of GS3-007a for pediatric growth hormone deficiency is planned, with the study currently not yet recruiting and sponsored by Changchun GeneSc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Growth Hormone Deficiency

Drugs mentioned

• GS3-007a

Snippet

Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd. | Conditions: Pediatric Growth Hormone Deficiency | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING